{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:48:13Z","timestamp":1794581293370,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health Commission of the Xinjiang Uygur Autonomous Region of China","award":["TSYC202401A062"],"award-info":[{"award-number":["TSYC202401A062"]}]},{"name":"the Health Commission of the Xinjiang Uygur Autonomous Region of China","award":["TSYC202401A062"],"award-info":[{"award-number":["TSYC202401A062"]}]},{"name":"the Health Commission of the Xinjiang Uygur Autonomous Region of China","award":["TSYC202401A062"],"award-info":[{"award-number":["TSYC202401A062"]}]},{"name":"the Health Commission of the Xinjiang Uygur Autonomous Region of China","award":["TSYC202401A062"],"award-info":[{"award-number":["TSYC202401A062"]}]},{"name":"the Health Commission of the Xinjiang Uygur Autonomous Region of China","award":["TSYC202401A062"],"award-info":[{"award-number":["TSYC202401A062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18385-0","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:11:49Z","timestamp":1758885109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study"],"prefix":"10.1038","volume":"15","author":[{"given":"Shuo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wufuer","family":"Yimaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilixiati","family":"Abudureheman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"18385_CR1","unstructured":"International Agency for Research on Cancer WHO. GLOBOCAN. (2022, accessed 10 Nov 2024).  https:\/\/gco.iarc.fr\/today\/en2024."},{"issue":"6","key":"18385_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA cancer J. Clin. 2020;70(4):313. Doi: 10.3322\/caac.21609]. CA Cancer J. Clin. 68 (6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"18385_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. &  Cabanillas, M. E. Thyroid cancer. Rev. JAMA 331 (5), 425\u2013435. doi:https:\/\/doi.org\/10.1001\/jama.2023.26348 (2024).","journal-title":"Rev. JAMA"},{"key":"18385_CR4","doi-asserted-by":"publisher","first-page":"108838","DOI":"10.1016\/j.surg.2024.06.066","volume":"177","author":"S Kurtom","year":"2025","unstructured":"Kurtom, S. et al. Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence. Surgery 177, 108838. https:\/\/doi.org\/10.1016\/j.surg.2024.06.066 (2025).","journal-title":"Surgery"},{"key":"18385_CR5","doi-asserted-by":"publisher","first-page":"1461372","DOI":"10.3389\/fmed.2024.146137","volume":"11","author":"F Firat Atay","year":"2024","unstructured":"Firat Atay, F. et al. A hybrid machine learning model combining association rule mining and classification algorithms to predict differentiated thyroid cancer recurrence. Front. Med. (Lausanne). 11, 1461372. https:\/\/doi.org\/10.3389\/fmed.2024.146137 (2024).","journal-title":"Front. Med. (Lausanne)"},{"issue":"11","key":"18385_CR6","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.ejso.2024.108626","volume":"50","author":"H Huang","year":"2024","unstructured":"Huang, H., Liu, Y., Yan, D., Liu, W. & Liu, S. The U-shaped association between age at diagnosis and recurrence in patients with papillary thyroid carcinoma: a retrospective single-institution cohort study. Eur. J. Surg. Oncol. 50 (11), 108626. https:\/\/doi.org\/10.1016\/j.ejso.2024.108626 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"18385_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26 (1), 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","journal-title":"Thyroid"},{"issue":"2","key":"18385_CR8","first-page":"813","volume":"24","author":"X Luo","year":"2019","unstructured":"Luo, X. & Wu, A. C. Y. Z. Y. J. B. Z. J. Analysis of risk factors for postoperative recurrence of thyroid cancer. J. BUON. 24 (2), 813\u2013818 (2019).","journal-title":"J. BUON"},{"issue":"12","key":"18385_CR9","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1245\/s10434-017-5780-z","volume":"24","author":"JW Yi","year":"2017","unstructured":"Yi, J. W. et al. Upregulation of the ESR1 gene and ESR ratio (ESR1\/ESR2) is associated with a worse prognosis in papillary thyroid carcinoma: the impact of the Estrogen receptor \u03b1\/\u03b2 expression on clinical outcomes in papillary thyroid carcinoma patients. Ann. Surg. Oncol. 24 (12), 3754\u20133762. https:\/\/doi.org\/10.1245\/s10434-017-5780-z (2017).","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"18385_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00423-011-0899-z","volume":"397","author":"A Konturek","year":"2012","unstructured":"Konturek, A., Barczy\u0144ski, M., Nowak, W. & Richter, P. Prognostic factors in differentiated thyroid cancer\u2013a 20-year surgical outcome study. Langenbecks Arch. Surg. 397 (5), 809\u2013815. https:\/\/doi.org\/10.1007\/s00423-011-0899-z (2012).","journal-title":"Langenbecks Arch. Surg."},{"issue":"27","key":"18385_CR11","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1200\/JCO.2018.78.5097","volume":"36","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer. J. Clin. Oncol. 36 (27), 2787\u20132795. https:\/\/doi.org\/10.1200\/JCO.2018.78.5097 (2018).","journal-title":"J. Clin. Oncol."},{"key":"18385_CR12","doi-asserted-by":"publisher","unstructured":"Parvathareddy, S. K. et al. The prognostic impact of tumor size and BRAF mutational status in middle Eastern differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 18, 785.  https:\/\/doi.org\/10.1210\/clinem\/dgae740 (2024).","DOI":"10.1210\/clinem\/dgae740"},{"issue":"14","key":"18385_CR13","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.3390\/cancers16142577","volume":"16","author":"J Park","year":"2024","unstructured":"Park, J., An, S., Bae, J. S., Kim, K. & Kim, J. S. Impact of tumor size on prognosis in differentiated thyroid cancer with gross extrathyroidal extension to strap muscles: redefining T3b. Cancers (Basel). 16 (14), 2577. https:\/\/doi.org\/10.3390\/cancers16142577 (2024).","journal-title":"Cancers (Basel)"},{"key":"18385_CR14","doi-asserted-by":"publisher","unstructured":"Liang, Z. et al. Ultrasound and clinical factors predicting central lymph node metastases in patients with unilateral multifocal papillary thyroid carcinoma. Asia Pac. J. Clin. Oncol. 24, 896.  https:\/\/doi.org\/10.1111\/ajco.14070 (2024).","DOI":"10.1111\/ajco.14070"},{"issue":"5","key":"18385_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3892\/ol.2024.14677","volume":"28","author":"W Sun","year":"2024","unstructured":"Sun, W., Hu, Q., Liu, Z., Zhang, Q. & Wang, J. Analysis of the clonal origin and differences in the biological behavior of multifocal papillary thyroid carcinoma. Oncol. Lett. 28 (5), 544. https:\/\/doi.org\/10.3892\/ol.2024.14677 (2024).","journal-title":"Oncol. Lett."},{"key":"18385_CR16","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. Nomograms to predict occult contralateral central lymph node metastases in unilateral papillary thyroid carcinoma with ipsilateral clinical lymph node metastasis. Oral Oncol. 14, 263.  https:\/\/doi.org\/10.1016\/j.oraloncology.2024.107051 (2024).","DOI":"10.1016\/j.oraloncology.2024.107051"},{"issue":"3","key":"18385_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.surg.2018.08.030","volume":"165","author":"HS Zhang","year":"2019","unstructured":"Zhang, H. S. et al. Total thyroidectomy\u2019s association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: analysis of Korean nationwide data. Surgery 165 (3), 629\u2013636. https:\/\/doi.org\/10.1016\/j.surg.2018.08.030 (2019).","journal-title":"Surgery"},{"issue":"Suppl 1","key":"18385_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.20471\/acc.2020.59.s1.10","volume":"59","author":"J Lukinovi\u0107","year":"2020","unstructured":"Lukinovi\u0107, J. & Bili\u0107, M. Overview of thyroid surgery complications. Acta Clin. Croat. 59 (Suppl 1), 81\u201386. https:\/\/doi.org\/10.20471\/acc.2020.59.s1.10 (2020).","journal-title":"Acta Clin. Croat"},{"key":"18385_CR19","doi-asserted-by":"publisher","unstructured":"Zhou, S. L. et al. Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma. World J. Surg. Oncol.  19 (1), 211. https:\/\/doi.org\/10.1186\/s12957-021-02326-y   (2021).","DOI":"10.1186\/s12957-021-02326-y"},{"key":"18385_CR20","doi-asserted-by":"publisher","unstructured":"Ye\u015filo\u011flu, A. A., U\u011fuz, A. H., Erdo\u011fan, K. E. & Sakman, G. Papillary microcarcinoma of the thyroid gland: evaluation of TERT and BRAFV-600E expression and their relationship with clinicopathological findings. Ann. Diagn. Pathol.  19, 256.  https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152369 (2024).","DOI":"10.1016\/j.anndiagpath.2024.152369"},{"key":"18385_CR21","doi-asserted-by":"publisher","unstructured":"Cong, R., Ouyang, H., Zhou, D., Li, X. & Xia, F. BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population. World J. Surg. Oncol. 22 (1), 259.  https:\/\/doi.org\/10.1186\/s12957-024-03539-7 (2024).","DOI":"10.1186\/s12957-024-03539-7"},{"issue":"12","key":"18385_CR22","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1089\/thy.2021.0267","volume":"31","author":"A Sato","year":"2021","unstructured":"Sato, A. et al. Circulating tumor DNA harboring the BRAFV600E mutation May predict poor outcomes of primary papillary thyroid cancer patients. Thyroid 31 (12), 1822\u20131828. https:\/\/doi.org\/10.1089\/thy.2021.0267 (2021).","journal-title":"Thyroid"},{"key":"18385_CR23","doi-asserted-by":"publisher","first-page":"9929782","DOI":"10.1155\/2024\/9929782","volume":"2024","author":"SK Parvathareddy","year":"2024","unstructured":"Parvathareddy, S. K. et al. Evaluating the influence of hashimoto\u2019s thyroiditis on clinico-pathological characteristics and prognostic outcomes of middle Eastern differentiated thyroid carcinoma. Int. J. Endocrinol. 2024, 9929782. https:\/\/doi.org\/10.1155\/2024\/9929782 (2024). Published 2024 Sep 14.","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"18385_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/diagnostics14020166","volume":"14","author":"A Donnici","year":"2024","unstructured":"Donnici, A. et al. Coexistence of hashimoto\u2019s thyroiditis in differentiated thyroid cancer: post-operative monitoring of anti-thyroglobulin antibodies and assessment of treatment response. Diagnostics (Basel). 14 (2), 166. https:\/\/doi.org\/10.3390\/diagnostics14020166 (2024).","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"18385_CR25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00268-019-05337-9","volume":"44","author":"I Lee","year":"2020","unstructured":"Lee, I., Kim, H. K., Soh, E. Y. & Lee, J. The association between chronic lymphocytic thyroiditis and the progress of papillary thyroid cancer. World J. Surg. 44 (5), 1506\u20131513. https:\/\/doi.org\/10.1007\/s00268-019-05337-9 (2020).","journal-title":"World J. Surg."},{"issue":"11","key":"18385_CR26","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1515\/cclm-2024-0405","volume":"62","author":"L Giovanella","year":"2024","unstructured":"Giovanella, L. et al. Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series. Clin. Chem. Lab. Med. 62 (11), 2307\u20132315. https:\/\/doi.org\/10.1515\/cclm-2024-0405 (2024).","journal-title":"Clin. Chem. Lab. Med."},{"key":"18385_CR27","doi-asserted-by":"publisher","unstructured":"Barrio, M. J. et al. Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy. Am. J. Surg. 3, 236. https:\/\/doi.org\/10.1016\/j.amjsurg.2024.115818 (2024).","DOI":"10.1016\/j.amjsurg.2024.115818"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18385-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:11:51Z","timestamp":1758885111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18385-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18385"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18385-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Approval Number: K202412-52), and informed consent was waived due to the retrospective nature of the study by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University which utilized anonymized clinical data without additional risk to participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"33140"}}